Literature DB >> 22123935

The clinical features of PML.

Joseph R Berger1.   

Abstract

The symptoms associated with progressive multifocal leukoencephalopathy (PML) reflect the location of pathologic brain lesions. These symptoms include visual deficits, cognitive impairment, and motor weakness; in patients with acquired immunodeficiency syndrome (AIDS), presenting signs can also include gait disturbance, dysarthria, dysphasia, and ocular palsy. Recently, PML has been observed in patients treated with biologic agents; natalizumab recipients currently represent the second largest group of patients with PML (behind patients with AIDS). Although brain biopsy is the most accurate and reliable method for diagnosing PML, it is rarely used today. Diagnosis is usually based on detection of JC virus in the cerebrospinal fluid by polymerase chain reaction, the clinical presentation, and demonstration of PML brain lesions on magnetic resonance imaging. With immune reconstitution, the prognosis of PML has improved markedly.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22123935     DOI: 10.3949/ccjm.78.s2.03

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  30 in total

Review 1.  Diagnostic assays for polyomavirus JC and progressive multifocal leukoencephalopathy.

Authors:  Martyn K White; Ilker K Sariyer; Jennifer Gordon; Serena Delbue; Valeria Pietropaolo; Joseph R Berger; Kamel Khalili
Journal:  Rev Med Virol       Date:  2015-12-14       Impact factor: 6.989

Review 2.  Animal Models for Progressive Multifocal Leukoencephalopathy.

Authors:  Martyn K White; Jennifer Gordon; Joseph R Berger; Kamel Khalili
Journal:  J Cell Physiol       Date:  2015-12       Impact factor: 6.384

Review 3.  Cas9 Ribonucleoprotein Complex Delivery: Methods and Applications for Neuroinflammation.

Authors:  Lee A Campbell; Christopher T Richie; Nishad S Maggirwar; Brandon K Harvey
Journal:  J Neuroimmune Pharmacol       Date:  2019-06-06       Impact factor: 4.147

Review 4.  Update on progressive multifocal leukoencephalopathy.

Authors:  Israel Steiner; Joseph R Berger
Journal:  Curr Neurol Neurosci Rep       Date:  2012-12       Impact factor: 5.081

5.  Risk of Biologic Therapy-Associated Progressive Multifocal Leukoencephalopathy: Use of the JC Virus Antibody Assay in the Treatment of Moderate-to-Severe Crohn's Disease.

Authors:  Gary R Lichtenstein; Stephen B Hanauer; William J Sandborn
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-11

Review 6.  Persistence and pathogenesis of the neurotropic polyomavirus JC.

Authors:  Hassen S Wollebo; Martyn K White; Jennifer Gordon; Joseph R Berger; Kamel Khalili
Journal:  Ann Neurol       Date:  2015-03-06       Impact factor: 10.422

Review 7.  Gene Editing for Treatment of Neurological Infections.

Authors:  Martyn K White; Rafal Kaminski; Hassen Wollebo; Wenhui Hu; Thomas Malcolm; Kamel Khalili
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

8.  JC polyomavirus reactivation is common following allogeneic stem cell transplantation and its preemptive detection may prevent lethal complications.

Authors:  T Wittmann; N Horowitz; N Benyamini; I Henig; T Zuckerman; J M Rowe; Z Kra-Oz; M Szwarcwort Cohen; I Oren; I Avivi
Journal:  Bone Marrow Transplant       Date:  2015-04-13       Impact factor: 5.483

Review 9.  Neurobehavioral Manifestations of Human Immunodeficiency Virus/AIDS: Diagnosis and Treatment.

Authors:  Elyse J Singer; April D Thames
Journal:  Neurol Clin       Date:  2016-02       Impact factor: 3.806

10.  Gallic acid-based small-molecule inhibitors of JC and BK polyomaviral infection.

Authors:  Bethany A O'Hara; Chamila Rupasinghe; Achani Yatawara; Gabriel Gaidos; Dale F Mierke; Walter J Atwood
Journal:  Virus Res       Date:  2014-06-21       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.